Parallel Advisors, LLC Uro Gen Pharma Ltd. Transaction History

Parallel Advisors, LLC

  • $4.87 Billion
  • Q2 2025

A detailed history of Parallel Advisors, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Parallel Advisors, LLC holds 400 shares of URGN stock, worth $8,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Holding current value
$8,064
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 07, 2025
BUY
$3.9 - $15.46 $1,560 - $6,184
400 New
400 $5,000
Q2 2022

Aug 01, 2022
SELL
$5.12 - $8.74 $15,600 - $26,630
-3,047 Closed
0 $0
Q1 2022

Apr 28, 2022
BUY
$5.92 - $9.73 $17,760 - $29,190
3,000 Added 6382.98%
3,047 $28,000
Q2 2021

Aug 06, 2021
SELL
$15.2 - $20.94 $30,400 - $41,880
-2,000 Reduced 97.7%
47 $1,000
Q1 2021

Apr 23, 2021
BUY
$17.99 - $26.96 $16,982 - $25,450
944 Added 85.58%
2,047 $40,000
Q4 2020

Feb 02, 2021
SELL
$17.54 - $25.43 $25,327 - $36,720
-1,444 Reduced 56.69%
1,103 $20,000
Q3 2020

Oct 27, 2020
BUY
$18.81 - $26.42 $28,214 - $39,630
1,500 Added 143.27%
2,547 $49,000
Q2 2020

Jul 16, 2020
BUY
$16.5 - $29.7 $17,275 - $31,095
1,047 New
1,047 $27,000
Q1 2020

Apr 27, 2020
SELL
$13.68 - $34.6 $36,936 - $93,420
-2,700 Closed
0 $0
Q4 2019

Jan 30, 2020
BUY
$21.11 - $34.86 $25,332 - $41,832
1,200 Added 80.0%
2,700 $90,000
Q3 2019

Nov 01, 2019
BUY
$23.83 - $36.44 $35,745 - $54,660
1,500 New
1,500 $36,000
Q2 2019

Aug 05, 2019
SELL
$32.75 - $40.35 $32,750 - $40,350
-1,000 Closed
0 $0
Q4 2018

Feb 05, 2019
BUY
$38.35 - $50.39 $19,175 - $25,195
500 Added 100.0%
1,000 $43,000
Q3 2018

Nov 01, 2018
SELL
$41.65 - $51.7 $62,475 - $77,550
-1,500 Reduced 75.0%
500 $24,000
Q2 2018

Jul 30, 2018
BUY
$48.35 - $65.33 $53,185 - $71,863
1,100 Added 122.22%
2,000 $99,000
Q1 2018

May 08, 2018
BUY
$38.64 - $57.54 $3,864 - $5,754
100 Added 12.5%
900 $45,000
Q3 2017

Nov 15, 2017
BUY
$17.15 - $32.72 $13,719 - $26,176
800
800 $35,000

Others Institutions Holding URGN

# of Institutions
144
Shares Held
41.5M
Call Options Held
116K
Put Options Held
42.1K
View Full List

About UroGen Pharma Ltd.

URGN Quotes by TradingView
  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $458M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email